ROTAVIRUS - ANVISA Registration 80254180246
Access comprehensive regulatory information for ROTAVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180246 and manufactured by REMEL EUROPE LIMITED. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, GUANGZHOU WONDFO BIOTECH CO. LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80254180246
25351151398201701
04930429000139
Company Information
Dates and Status
Apr 24, 2017
VIGENTE
09/18/2025 19:00:01
ROTAVÍRUS
ROTAVÍRUS TESTE RÁPIDO CELER
GUANGZHOU WONDFO BIOTECH CO. LTD
80537410127
Mar 05, 2025
ROTAVÍRUS
RIDASCREEN® Rotavirus
R-BIOPHARM AG
82890930003
Jan 27, 2025
ROTAVÍRUS
CORIS Bioconcept® Rota-Strip
Nanosens Ltda
81546350067
Apr 22, 2024
ROTAVÍRUS
Rotavírus TF Quicktest
BIO BRASIL CIENCIA E TECNOLOGIA LTDA
81249610016
Oct 30, 2023
ROTAVÍRUS
Família Teste Rápido para Detecção do Combo Rotavírus e Adenovírus em Cassete (Fezes)
HANGZHOU ALLTEST BIOTECH CO. LTD
81325990299
Sep 04, 2023

